ea0089c25 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022
Heying Duan
, Hong Song
, Valentina Ferri
, George Fisher
, Shagufta Shaheen
, Jagruti Sha
, Judy Nguyen
, Farshad Moradi
, Ben Franc
, Guido Davidzon
, Andrei Iagaru
, Aparici Carina Mari
Background: We aimed to evaluate the added information provided by 68Ga-DOTATATE PET after two cycles of peptide receptor radionuclide therapy (PRRT) in patients with somatostatin receptor (SSTR)-expressing neuroendocrine tumors (NET).Methods: In this retrospective study, 105 patients (54 women and 51 men, 62.5±10.5-year-old) with progressive NET treated with at least two cycles of 177Lu-DOTATATE were included. All patients had <...